Market Cap
$10.97B$2.26M+0.02%
Summary
- Current Value
- As of today, RNA market cap is $11B, up +0.02% in the current trading session
- Category
- Based on its current market cap, RNA falls into the large-cap category
- Historical Performance
- RNA market cap is up +0.98% year-to-date, and up +160.71% over the past 365 days
- All-Time High Comparison
- RNA market cap is currently -0.13% below its historical high of $11B set on
- 3-Year Low Comparison
- RNA market cap is +2941.09% above its 3-year low of $361M reached on
- Sector Comparison
- RNA market cap is higher than 91.48% of companies in Healthcare sector
Market Cap Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $11B | +0.0% | +0.8% | +4.4% | +1.0% | +160.7% | +547.3% | +1201.8% | |
| Price | $72.84 | +0.0% | +0.8% | +4.4% | +1.0% | +107.5% | +199.7% | +224.6% | |
| Shares Outstanding | 150.68M | 0.0% | – | – | – | +25.7% | +116.0% | +301.1% | |
| PE Ratio | - | – | – | – | – | – | – | – | |
| TTM Revenue | $20.87M | +94.5% | – | +94.5% | – | +106.3% | +151.2% | +242.7% | |
| TTM EPS | -$4.17 | -17.2% | – | -17.2% | – | -43.9% | -27.8% | -306.3% | |
| $9.15B | +0.0% | +1.0% | +5.3% | +1.2% | +237.0% | +735.2% | +1673.5% | ||
| TTM Dividend Per Share | - | – | – | – | – | – | – | – | |
| TTM Net Income | -$549.79M | -20.6% | – | -20.6% | – | -96.0% | -239.2% | -1328.7% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $11B | -0.1% | |
| 3M | $11B | -0.1% | |
| 6M | $11B | -0.1% | |
| 1Y | $11B | -0.1% | |
| 3Y | $11B | -0.1% | |
| 5Y | $11B | -0.1% | |
| All | $11B | -0.1% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $11B | +0.8% | |
| 3M | $11B | +4.4% | |
| 6M | $5B | +107.8% | |
| 1Y | $3B | +278.2% | |
| 3Y | $361M | +2941.1% | |
| 5Y | $361M | +2941.1% | |
| All | $361M | +2941.1% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $11B | +1.0% | |
| $11B | +211.7% | |
| $3B | +386.0% | |
| $717M | -53.7% |
| Date | Value | Change |
|---|---|---|
| $2B | +36.4% | |
| $1B | +18.4% | |
| $959M | - |
FAQ
What is the current market cap of RNA?
As of today, RNA market cap is $11B
What market cap category does RNA fall into?
Based on its current market cap, RNA falls into the large-cap category
What is RNA market cap today change?
RNA market cap is up +0.02% today
What is 1-year change in RNA market cap?
RNA market cap is up +160.71% year-over-year
How far is RNA market cap from its all-time high?
RNA market cap is currently -0.13% below its historical high of $11B set on February 3, 2026
How does RNA market cap rank versus sector peers?
RNA market cap is higher than 91.48% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- RNA Official Website www.aviditybiosciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1599901/000159990125000210/0001599901-25-000210-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990125000059/0001599901-25-000059-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna